UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, D.C. 20549FORM 11-KFOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE,
  SAVINGS
  AND SIMILAR PLANS PURSUANT TO SECTION 15 (d) OF
  THE SECURITIES EXCHANGE ACT OF 1934(Mark One)X
  ANNUAL REPORT PURSUANT TO
  SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31, 2005orTRANSITION REPORT PURSUANT
  TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from toCommission file number 1-3619A.
  Full title of the Plan and
  the address of the plan, if different from that of the issuer named below:PFIZER SAVINGS PLANB.
  Name of issuer of the
  securities held pursuant to the plan and the address of its principal
  executive office:PFIZER INC.
  235 EAST 42ND STREET
  NEW YORK, NEW YORK 10017




PFIZER SAVINGS PLAN INDEX

|                                                                                                 |     
|------------------------------------------------------------------------------------------------ | ----
|                                                                                                 | Page
|FINANCIAL STATEMENTS                                                                             |     
|Report of Independent
  Registered Public Accounting Firm                                        | 3   
|Statements of Net Assets Available for Plan Benefits                                             | 4   
|Statements of Changes in Net Assets Available for
  Plan Benefits                                | 5   
|Notes to Financial
  Statements                                                                  | 6   
|                                                                                                 |     
|SCHEDULES                                                                                        |     
|Schedule H, Line 4i -
  Schedule of Assets (Held at End of Year) at December 31, 2005            | 12  
|Schedule H, Line 4j - Schedule of
  Reportable Transactions for the Year Ended December 31, 2005 | 14  
|Signature                                                                                        | 15  
|                                                                                                 |     
|EXHIBITS                                                                                         |     
|23                                                                                               | --  
|                                                                                                 |     







REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM

To the Savings Plan Committee
Pfizer Savings Plan:

We
have audited the accompanying statements of net assets available for plan
benefits of the Pfizer Savings Plan (the Plan) as of December 31, 2005 and
2004, and the related statements of changes in net assets available for plan
benefits for each of the years then ended. These financial statements are the
responsibility of the Plan's management. Our responsibility is to express an
opinion on these financial statements based on our audits.

We
conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we
plan and perform an audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.

In
our opinion, the financial statements referred to above present fairly, in all
material respects, the net assets available for plan benefits as of
December 31, 2005 and 2004, and the changes in net assets available for
plan benefits for the years then ended, in conformity with U.S. generally
accepted accounting principles.

Our
audits were performed for the purpose of forming an opinion on the basic
financial statements taken as a whole. The supplemental schedule H, line 4i -
schedule of assets (held at end of year) as of December 31, 2005 and
schedule H, line 4j - schedule of reportable transactions for the year ended
December 31, 2005 are presented for the purpose of additional analysis and
are not a required part of the basic financial statements but are supplementary
information required by the Department of Labor's Rules and Regulations for
Reporting and Disclosure under the Employee Retirement Income Security Act of
1974. These supplemental schedules are the responsibility of the Plan's
management. The supplemental schedules have been subjected to the auditing
procedures applied in the audits of the basic financial statements and, in our
opinion, are fairly stated in all material respects in relation to the basic
financial statements taken as a whole.

/s/
KPMG LLP

Memphis, Tennessee

June 22, 2006



PFIZER SAVINGS PLAN
STATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS

|                                       | December 31,
|-------------------------------------- | ------------
|(thousands of dollars)                 | 2005        
|                                       |             
|Assets:                                |             
|                                       |             
|Investments:                           |             
|Pfizer Inc common stock                | $2,089,738  
|Mutual funds                           | 1,779,712   
|Fixed income funds                     | 324,883     
|Bond funds                             | 174,587     
|                                       | 4,368,920   
|Loans to participants                  | 72,052      
|Total investments                      | 4,440,972   
|                                       |             
|Receivables:                           |             
|Participant contributions              | 8,547       
|Company contributions                  | 3,483       
|Receivable for securities sold         | 932         
|Interest receivable                    | 3,367       
|Total receivables                      | 16,329      
|Total assets                           | 4,457,301   
|                                       |             
|Liabilities:                           |             
|Payable for securities purchased       | (1,145)     
|Investment management fees payable     | (134)       
|Total liabilities                      | (1,279)     
|Net assets available for plan benefits | $4,456,022  



See Notes to Financial Statements which are an
integral part of these financial statements.



PFIZER SAVINGS
PLAN
STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS

|                                                      | Year-ended December 31,
|----------------------------------------------------- | -----------------------
|(thousands of dollars)                                | 2005                   
|                                                      |                        
|Additions/(Reductions):                               |                        
|Additions/(reductions) to net assets
  attributed to: |                        
|Investment income/(loss):                             |                        
|Net depreciation in fair value of investments         | $  (206,038)           
|Pfizer Inc common stock dividends                     | 70,378                 
|Interest income                                       | 21,107                 
|Dividend income                                       | 4,705                  
|Interest income from loans to
  participants          | 4,032                  
|                                                      | (105,816)              
|Less: Investment management fees                      | (739)                  
|                                                      | (106,555)              
|                                                      |                        
|Transfers into Plan                                   | 1,993                  
|                                                      |                        
|Contributions:                                        |                        
|Participant                                           | 300,873                
|Company                                               | 121,495                
|                                                      | 422,368                
|Total additions/(reductions)                          | 317,806                
|                                                      |                        
|Deductions:                                           |                        
|Deductions from net assets attributed
  to:           |                        
|Benefits paid to participants                         | (569,474)              
|Transfers out of Plan,                                | --                     
|Total deductions                                      | (569,474)              
|                                                      |                        
|Net decrease                                          | (251,668)              
|Net assets
  available for plan benefits:             |                        
|Beginning of year                                     | 4,707,690              
|End of year                                           | $4,456,022             



See Notes to Financial Statements which are an
integral part of these financial statements.





PFIZER SAVINGS PLAN
Notes to Financial Statements
December 31, 2005 and 2004
(in thousands of dollars)

1.     Description
of the Plan

The
Pfizer Savings Plan (the Plan) is a defined contribution plan. Participation in
the Plan is open to any employee of Pfizer Inc (the "Plan Sponsor"), or
an affiliate, which has with the consent of the Plan Sponsor adopted the Plan ("Participating
Employers"), and who is included within a group or class designated by the
Plan Sponsor as set forth in the Plan document. The Plan is subject to the
provisions of the Employee Retirement Income Security Act of 1974, as amended ("ERISA")
and the Internal Revenue Code of 1986, as amended (the "Code").

The
following is a general description of certain provisions of the Plan.
Participants should refer to the Plan document for more complete information.

Plan Administration

The Savings Plan Committee of the Plan monitors and
reports on the selection and termination of the trustee and investment managers
and on the investment activity and performance.

Administrative Costs

Except for investment management fees and redemption
fees associated with certain Fidelity fund options, all costs and expenses of
administering the Plan are paid and absorbed by the Plan Sponsor and
Participating Employers (collectively, the "Company").

Contributions

Participants may make contributions on an after-tax
basis and/or on a before-tax basis (that is, choose to reduce their compensation
and have the Company contribute such amount to the Plan on their behalf).
Contributions are subject to certain restrictions under the Code. Contributions
of up to 3% of compensation are matched 100% by the Company and the next 3% are
matched 50%. Employee contributions in excess of 6% are not matched.
Participants who are eligible employees are permitted to roll over into the
Plan eligible distributions from other qualified employer sponsored savings
plans and conduit IRAs.

Participant Accounts

Each participant's account is credited with the
participant's contributions, allocations of the Company's contributions and
Plan earnings. Allocations are based on participant earnings or account
balances, as defined. Participants are immediately vested in the full value of their
account (i.e., participant's and Company's contributions), except for certain
accounts transferred from the Warner-Lambert Savings and Stock Plan.

Investment Options

Nonparticipant
Directed Fund --The Company contributes to one fund:

|                                                                                                                                                                                          |                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Pfizer
  Match Fund                                                                                                                                                                       | --                                                 | This fund invests employer contributions in the common
  stock of Pfizer Inc. A participant who has attained both age 55 and completed
  ten or more years of participation in the Plan may direct that a certain
  percentage of assets then in the Pfizer Match Fund be transferred (up to a
  total of 25% during the first 5 years of eligibility and up to a total of 50%
  thereafter in 1% increments) out of the Pfizer Match Fund into any of the
  other investment funds except the Pfizer Company Stock Fund. The fund may
  invest up to 0.25% of the fund balance in an S&P 500 index fund for
  purposes of liquidity.

  Effective January 1, 2006, the Plan was amended to
  lower the minimum age requirement for diversifying Company contributions out
  of the Pfizer Match Fund from age 55 to age 40, and the ten year
  participation requirement was eliminated.  A participant who has attained age
  40 may diversify up to 25% of their total units in the Pfizer Match Fund. 
  The amount of total units eligible for diversification increases 25% each 5
  years through age 55 whereby the participant may diversify 100% of their
  units in the fund.
|                                                                                                                                                                                         
|                                                                                                                                                                                         
|Participant Directed Funds -- Each participant in
  the Plan elects to have his or her contributions invested in any one or any
  combination of the following nineteen investment funds:
|(a)                                                                                                                                                                                       | Intermediate Treasury Index Fund*                 
|(b)                                                                                                                                                                                       | Russell 2000 Index Fund                           
|(c)                                                                                                                                                                                       | S&P
  500 Mutual Fund*                            
|(d)                                                                                                                                                                                       | Pfizer
  Company Stock Fund                       
|(e)                                                                                                                                                                                       | T.
  Rowe Price Stable Value Fund                 
|(f)                                                                                                                                                                                       | T.
  Rowe Price Value Fund                        
|(g)                                                                                                                                                                                       | Fidelity
  Low Price Stock Fund (1)               
|(h)                                                                                                                                                                                       | Fidelity
  Dividend Growth Fund                   
|(i)                                                                                                                                                                                       | Fidelity
  Growth Company Fund                    
|(j)                                                                                                                                                                                       | Fidelity
  Mid Cap Stock Fund                     
|(k)                                                                                                                                                                                       | T.
  Rowe Price Small Cap Stock Fund              
|(l)                                                                                                                                                                                       | Capital Guardian International Fund               
|(m)                                                                                                                                                                                       | T. Rowe Price Health Sciences Fund                
|(n)                                                                                                                                                                                       | Fidelity Select Technology Fund                   
|(o)                                                                                                                                                                                       | Barclays Global Investors Lifepath Retirement Fund
|(p)                                                                                                                                                                                       | Barclays Global Investors Lifepath 2010 Fund      
|(q)                                                                                                                                                                                       | Barclays Global Investors Lifepath 2020 Fund      
|(r)                                                                                                                                                                                       | Barclays Global Investors Lifepath 2030 Fund      
|(s)                                                                                                                                                                                       | Barclays Global Investors Lifepath 2040 Fund      
|                                                                                                                                                                                          |                                                   
|*                                                                                                                                                                                         | Northern
  Trust sponsored fund.                  
|(1)                                                                                                                                                                                       | Closed
  to new investors as of July 30, 2004     
|                                                                                                                                                                                          |                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

The
trustee of the Plan, The Northern Trust Company, manages investments in its
sponsored funds and, therefore, is deemed a related party. The Plan's trust
agreement provides that any portion of any of the investment funds may, pending
its permanent investment or distribution, be invested in short-term
investments.

Eligibility

Generally, all domestic employees of the Company,
except certain employees who are either covered by a collective bargaining
agreement and have not negotiated to participate in the Plan, or employed by a
unit not designated for participation in the Plan, are eligible to enroll in
the Plan on their date of hire.

Loans to
Participants

Plan participants are permitted to borrow against
their vested account balance. The minimum amount a participant may borrow is one
thousand dollars and the maximum amount is the lesser of 50% of the vested
account balance reduced by any current outstanding loan balance, or fifty
thousand dollars, reduced by the highest outstanding loan balance in the
preceding 12 months.

Under
the terms of the Plan, loans must be repaid within five years, unless the funds
are used to purchase a primary residence. Primary residence loans must be
repaid within 15 years at the participant's option. The interest rate on
all loans is based on the prime rate, as defined, plus 1%. Interest paid by the
participant is credited to the participant's account. Interest income from
participant loans is recorded by the Trustee as earned in the nonparticipant
and participant directed funds in the same proportion as the original loan
issuance.  Interest rates on outstanding loans ranged from 4.14% to 11.64% at December
31, 2005 and from 4.00% to 10.50% at December 31, 2004.

In
the event of termination, participants will have 90 days to repay the loan
before the loan is taxed and penalized with an additional 10% tax.

Benefit Payments

Upon separation from service, retirement or
disability, a participant is entitled to receive the full value of the account
balance in the form of a lump sum distribution. A participant generally may
elect to receive his account balance at any time up to the later of
13 months after termination or age 65, subject to the provisions of
the Plan. In the event of a participant's death, a spouse beneficiary generally
may elect payment at any time or defer payments until the later of
13 months from the date of death or when the participant would have
reached age 65.  A nonspouse beneficiary generally may defer payment up until
13 months from the date of participant's death.

In-Service Withdrawals

Participants in the Plan may make withdrawals from their
account balances subject to the provisions of the Plan.

Plan Termination

The Plan Sponsor expects to continue the Plan
indefinitely, but reserves the right to amend, suspend or discontinue it in whole
or in part at any time by action of the Plan Sponsor's Board of Directors or
its authorized designee. In the event of termination of the Plan, each
participant shall be entitled to the full value of his or her account balance
as though he or she had retired as of the date of such termination. No part of
the invested assets established pursuant to the Plan will at any time revert to
the Company, except as otherwise permitted under ERISA.

2.     Summary of Significant
Accounting Policies

Basis of Accounting

The financial statements of the Plan are prepared on
the accrual basis of accounting, however, benefit payments are recorded when
paid. For treatment of benefits payable, refer to Note 8.

Use of Estimates

The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America
requires the plan administrator to make estimates and assumptions that affect
the reported amounts of assets and liabilities at the date of the financial
statements, the reported amounts of increases and decreases to net assets
during the reporting period and disclosure of contingent assets and liabilities.
Actual results could differ from those estimates.

InvestmentValuation

Company common stock is valued at the closing market
price on the last business day of the year. Bond funds are recorded at fair
value based on market or dealer quotes on the last business day of the year.
Fixed income funds and mutual funds are recorded at fair value based on the
closing market prices obtained from national exchanges of the underlying
investments of the respective fund as of the last business day of the year. Investments
in guaranteed investment contracts ("GICs") and synthetic investment
contracts ("SICs") are reported at their contract value by the
insurance companies and underlying banks, respectively, because these
investments have fully benefit-responsive features (see Note 6). Loans to
participants, which are subject to various interest rates, and short-term
securities are recorded at cost which approximates fair value. Short-term
securities primarily consist of U.S. Government securities.

The
Plan presents in the statement of changes in net assets available for plan
benefits, the net appreciation/(depreciation) in the fair value of its
investments which consists of the realized gains and losses and the unrealized
appreciation/(depreciation) on those investments.

Forfeitures

Forfeited amounts are used to reduce Company
contributions.

Riskand
Uncertainties

Investment securities, including Pfizer Inc common
stock, are exposed to various risks, such as interest rate, market and credit
risks. Due to the level of risk associated with certain investment securities,
it is at least reasonably possible that changes in their values could occur in
the near term and that such changes could materially affect participants'
account balances and the amounts reported in the Statement of Net Assets
Available for Plan Benefits.

Investment Transactions

Purchases and sales of securities are reflected on a trade-date
basis. Dividend income is recorded on the ex-dividend date. Interest income is
recorded as earned.

3.     Transfers Into and Out
Of the Plan

In
February 2004, the Company completed the acquisition of Esperion Therapeutics,
Inc. As a result, in April 2005, net assets of the Esperion Therapeutics, Inc.
401(k) Savings Plan, in the amount of $1,993, were transferred into the Plan.

In
March 2003, the Company sold the Adams confectionary business and the
Schick-Wilkinson Sword shaving products business.  As a result in 2004, net
assets of Plan participants who were employees of these businesses of $298 were
transferred out of the Plan.

4.     Tax Status of the Plan

The
Internal Revenue Service has determined and informed the Plan Sponsor by letter
dated August 19, 2005 that the Plan and related trust are designed in
accordance with the applicable sections of the Code. Accordingly, no provision
has been made for federal income taxes.



5.     Investments

The
following investments represent 5% or more of the Plan's net assets available
for plan benefits.

|                                       | December 31,
|-------------------------------------- | ------------
|(thousands of dollars)                 | 2005        
|                                       |             
|Pfizer Inc common stock*               | $2,089,738  
|Fidelity Low Priced Stock Mutual Fund. | 228,178     
|S&P 500 Mutual Fund                    | 390,899     



|* | Includes nonparticipant
  directed 51,761,413 shares and participant directed 37,849,979 shares at
  December 31, 2005 and nonparticipant directed 54,155,672 shares and
  participant directed 42,348,622 shares at December 31, 2004.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The
Plan's investments (including gains and losses on investments sold, as well as
held during the year) appreciated/(depreciated) in value as follows:

|                                                                | Year-ended December 31,
|--------------------------------------------------------------- | -----------------------
|(thousands of
  dollars)                                        | 2005                   
|                                                                |                        
|Net appreciation/(depreciation) in fair
  value of investments: |                        
|Pfizer
  Inc common stock                                       | $(337,223)             
|Mutual
  funds                                                  | 135,513                
|Bond
  funds                                                    | (4,328)                
|                                                                | $(206,038)             
|                                                                |                        



6.     Investment
Contracts with Insurance Companies

The T.Rowe Price Stable Value Fund consists primarily
of fully benefit responsive GIC's and SIC's. The contract value of the GICs and
SICs represents contributions made under the contract and related earnings
offset by participant withdrawals. At December 31, 2005 and 2004, the Plan held
GICs with a contract value of $69,413 and $64,346 and SICs with a contract
value of $235,780 and $210,776, respectively. Participants may ordinarily
direct the withdrawal or transfer of all or a portion of their investments at
contract value.

There are no reserves against contract value for
credit risk of the contract issuers or otherwise. The average portfolio yields
were approximately 4% for both 2005 and 2004. The crediting interest rates were
approximately 5% for 2005 and 4% for 2004. For GICs, the crediting interest
rate, specified in the contract, is agreed upon with the issuers and is
maintained for the life of the contract. For SICs, the rate is based on a
formula which consists of the yield to maturity, duration, and the book and
market values. The rate for SICs is periodically reset, usually quarterly, and
cannot be reset below 0%.

7.     Nonparticipant
directed Investments

Information about the net assets and significant
components of the changes in net assets relating to the nonparticipant-directed
investments is as follows:

|                                       | December 31,
|-------------------------------------- | ------------
|(thousands of dollars)                 | 2005        
|                                       |             
|Net Assets:                            |             
|Investments, at fair value:            |             
|Pfizer Inc common stock                | $1,207,076  
|Mutual funds                           | 2,047       
|Total investments                      | 1,209,123   
|Receivables:                           |             
|Company contributions                  | 3,483       
|Net assets available for plan benefits | $1,212,606  



|                                                | Year-ended December 31,
|----------------------------------------------- | -----------------------
|(thousands of dollars)                          | 2005                   
|                                                |                        
|Changes in Net Assets:                          |                        
|Net investment loss:                            |                        
|Net depreciation in fair value of
  investments | $(191,756)             
|Pfizer Inc common stock dividends               | 40,077                 
|Interest and dividend income                    | 203                    
|                                                | (151,476)              
|Contributions and other:                        |                        
|Company
  contributions                         | 126,128                
|Withdrawals                                     | (223,952)              
|Transfers
  out of Plan, net                    | --                     
|Loan
  transaction transfers, net               | 392                    
|                                                | (97,432)               
|Net decrease                                    | $(248,908)             



8.     Reconciliation
of Financial Statements to Form 5500

Amounts
allocated to withdrawing participants are recorded on Form 5500 for benefit
claims that have been processed and approved for payment prior to December 31
but not yet paid as of that date.

The
following is a reconciliation of net assets available for plan benefits per the
financial statements to the Plan's Form 5500 filed for 2004 and expected
to be filed for 2005.

|                                                                      | December 31,
|--------------------------------------------------------------------- | ------------
|(thousands of dollars)                                                | 2005        
|                                                                      |             
|Net assets available for plan benefits
  per the financial statements | $4,456,022  
|Amounts allocated to withdrawing
  participants                       | (1,149)     
|Net assets available for plan benefits
  per Form 5500                | $4,454,873  



The following is a reconciliation of benefits paid to
participants per the financial statements to the Form 5500:

|                                                                            | December 31,
|--------------------------------------------------------------------------- | ------------
|(thousands of dollars)                                                      | 2005        
|                                                                            |             
|Benefits paid to participants per the
  financial statements                | $569,474    
|Add:  Amounts allocated to
  withdrawing participants at December 31, 2005  | 1,149       
|Less:  Amounts allocated to
  withdrawing participants at December 31, 2004 | (166)       
|Benefits paid to participants per the
  Form 5500                           | $570,457    



SCHEDULE
I
PFIZER SAVINGS PLAN
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
December 31, 2005
(thousands of dollars)

|                                                                              | Interest
   Rate | Maturity
   Date       | Number of
   Shares or
   Units |  | Cost       | Fair
   Value
|----------------------------------------------------------------------------- | ---------------- | ---------------------- | ------------------------------- |  | ---------- | -------------
|                                                                              |                  |                        |                                 |  |            |              
|Nonparticipant Directed                                                       |                  |                        |                                 |  |            |              
|Pfizer Inc* Common Stock                                                      |                  |                        | 51,761,413                      |  | $567,688   | $1,207,076   
|S&P 500 Mutual Fund                                                           |                  |                        | 617                             |  | 2,069      | 2,047        
|Total nonparticipant-directed investments                                     |                  |                        |                                 |  | $569,757   | $1,209,123   
|                                                                              |                  |                        |                                 |  |            |              
|Participant Directed                                                          |                  |                        |                                 |  |            |              
|Pfizer Inc* Common Stock                                                      |                  |                        | 37,849,979                      |  | $444,690   | $882,662     
|                                                                              |                  |                        |                                 |  |            |              
|Bond Funds:                                                                   |                  |                        |                                 |  |            |              
|U.S. Treasury Notes                                                           | 3.000%           | 11/15/2007             | 9,300,000                       |  | 9,272      | 9,068        
|U.S. Treasury Notes                                                           | 4.250%           | 8/15/2013              | 6,200,000                       |  | 6,056      | 6,145        
|U.S. Treasury Notes                                                           | 3.125%           | 9/15/2008              | 3,700,000                       |  | 3,731      | 3,582        
|U.S. Treasury Notes                                                           | 4.250%           | 11/15/2013             | 8,000,000                       |  | 7,904      | 7,924        
|U.S. Treasury Bonds                                                           | 4.000%           | 6/15/2009              | 5,500,000                       |  | 5,599      | 5,433        
|U.S. Treasury Notes                                                           | 4.000%           | 4/15/2010              | 2,000,000                       |  | 1,979      | 1,971        
|U.S. Treasury Notes                                                           | 4.125%           | 5/15/2015              | 3,500,000                       |  | 3,484      | 3,423        
|U.S. Treasury Notes                                                           | 3.625%           | 6/30/2007              | 5,000,000                       |  | 4,999      | 4,943        
|U.S. Treasury Notes                                                           | 4.500%           | 11/15/2015             | 3,000,000                       |  | 3,006      | 3,025        
|U.S. Treasury Notes                                                           | 6.500%           | 2/15/2010              | 2,000,000                       |  | 2,150      | 2,157        
|U.S. Treasury Notes                                                           | 5.000%           | 2/15/2011              | 5,350,000                       |  | 5,502      | 5,510        
|U.S. Treasury Notes                                                           | 4.375%           | 5/15/2007              | 6,000,000                       |  | 6,300      | 5,995        
|U.S. Treasury Notes                                                           | 2.625%           | 5/15/2008              | 7,000,000                       |  | 6,796      | 6,724        
|U.S. Treasury Notes                                                           | 4.750%           | 5/15/2014              | 2,700,000                       |  | 2,738      | 2,766        
|U.S. Treasury Notes                                                           | 6.000%           | 8/15/2009              | 4,100,000                       |  | 4,579      | 4,321        
|U.S. Treasury Notes                                                           | 5.750%           | 8/15/2010              | 6,700,000                       |  | 7,129      | 7,088        
|U.S. Treasury Notes                                                           | 3.250%           | 8/15/2007              | 6,500,000                       |  | 6,577      | 6,382        
|U.S. Treasury Notes                                                           | 3.750%           | 3/31/2007              | 9,600,000                       |  | 9,611      | 9,518        
|U.S. Treasury Notes                                                           | 4.250%           | 11/15/2014             | 4,000,000                       |  | 3,988      | 3,953        
|U.S. Treasury Notes                                                           | 2.625%           | 3/15/2009              | 12,000,000                      |  | 11,875     | 11,375       
|U.S. Treasury Notes                                                           | 3.625%           | 5/15/2013              | 5,500,000                       |  | 5,467      | 5,246        
|U.S. Treasury Notes                                                           | 2.250%           | 2/15/2007              | 7,500,000                       |  | 7,387      | 7,321        
|U.S. Treasury Notes                                                           | 3.000%           | 2/15/2008              | 5,200,000                       |  | 5,231      | 5,054        
|U.S. Treasury Notes                                                           | 6.625%           | 5/15/2007              | 3,500,000                       |  | 3,684      | 3,602        
|U.S. Treasury Notes                                                           | 4.750%           | 11/15/2008             | 6,000,000                       |  | 5,726      | 6,058        
|U.S. Treasury Notes                                                           | 3.875%           | 2/15/2013              | 4,000,000                       |  | 4,054      | 3,877        
|U.S. Treasury Notes                                                           | 3.375%           | 12/15/2008             | 9,600,000                       |  | 9,574      | 9,336        
|U.S. Treasury Notes                                                           | 3.375%           | 10/15/2009             | 7,750,000                       |  | 7,629      | 7,484        
|U.S. Treasury Notes                                                           | 4.000%           | 11/15/2012             | 4,500,000                       |  | 4,492      | 4,403        
|U.S. Treasury Notes                                                           | 4.875%           | 2/15/2012              | 2,000,000                       |  | 2,095      | 2,053        
|U.S. Treasury Notes                                                           | 5.000%           | 8/15/2011              | 3,000,000                       |  | 3,069      | 3,097        
|U.S. Treasury Notes                                                           | 5.625%           | 5/15/2008              | 5,600,000                       |  | 5,858      | 5,753        
|                                                                              |                  |                        |                                 |  | 177,541    | 174,587      
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|                                                                              |                  |                        |                                 |  |            |              
|Mutual Funds:                                                                 |                  |                        |                                 |  |            |              
|S&P 500 Mutual Fund                                                           |                  |                        | 117,279                         |  | 303,966    | 388,854      
|Russell 2000 Mutual Fund                                                      |                  |                        | 16,794                          |  | 12,252     | 13,099       
|Barclays Global Investors Lifepath
  Retirement Fund                          |                  |                        | 1,244,311                       |  | 21,738     | 22,447       
|Barclays Global Investors Lifepath 2010 Fund                                  |                  |                        | 2,500,012                       |  | 46,513     | 48,375       
|Barclays Global Investors Lifepath 2020 Fund                                  |                  |                        | 2,462,262                       |  | 46,988     | 49,393       
|Barclays Global Investors Lifepath 2030 Fund                                  |                  |                        | 1,902,889                       |  | 37,061     | 39,180       
|Barclays Global Investors Lifepath 2040 Fund                                  |                  |                        | 1,304,237                       |  | 25,716     | 27,402       
|Fidelity Mid Cap stock Fund                                                   |                  |                        | 5,193,389                       |  | 113,424    | 137,988      
|Fidelity Dividend Growth Fund                                                 |                  |                        | 2,430,178                       |  | 64,290     | 69,965       
|Fidelity Growth Company Fund                                                  |                  |                        | 2,335,563                       |  | 115,429    | 148,612      
|Fidelity Low Price Stock Fund                                                 |                  |                        | 5,587,125                       |  | 184,118    | 228,178      
|Capital Guardian International Fund                                           |                  |                        | 11,937,867                      |  | 122,633    | 133,465      
|Fidelity Select Technology Fund                                               |                  |                        | 806,757                         |  | 44,450     | 50,947       
|T.Rowe Price Health Science                                                   |                  |                        | 2,585,121                       |  | 53,354     | 64,809       
|T.Rowe Price Small Cap Stock                                                  |                  |                        | 5,076,275                       |  | 141,506    | 166,553      
|T.Rowe Price Value Fund                                                       |                  |                        | 8,058,120                       |  | 161,989    | 188,398      
|                                                                              |                  |                        |                                 |  | 1,495,427  | 1,777,665    
|Fixed Income Funds:                                                           |                  |                        |                                 |  |            |              
|T.Rowe Price, Stable Value Fund--Synthetic Guaranteed
  Investment Contracts: |                  |                        |                                 |  |            |              
|Bank of America Contract #03-099..                                            | 4.25%            | 12/10/2010             | 59,229,256                      |  | 59,229     | 59,229       
|CDC Contract #WR-1828-01                                                      | 4.25%            | 12/10/2010             | 59,222,089                      |  | 59,222     | 59,222       
|Rabobank Contract #WLC-100301                                                 | 4.25%            | 12/10/2010             | 59,225,670                      |  | 59,226     | 59,226       
|State Street Contract #96028                                                  | 5.10%            | --                     | 58,102,354                      |  | 58,103     | 58,103       
|T.Rowe Price, Stable Value Fund--Guaranteed
  Investment Contracts:           |                  |                        |                                 |  |            |              
|GE Capital Assurance, Contract #GS-3719                                       | 5.61%            | 12/15/2006             | 4,090,211                       |  | 4,090      | 4,090        
|GE Life and Annuity, Contract #GS-3713                                        | 5.71%            | 9/15/2006              | 6,168,998                       |  | 6,169      | 6,169        
|GE ING USA Annuity, Contract #IUS0178                                         | 4.46%            | 3/10/2010              | 5,000,000                       |  | 5,000      | 5,000        
|Metropolitan Life Ins., Contract #GC29272                                     | 4.77%            | 2/10/2010              | 2,592,635                       |  | 2,593      | 2,593        
|Metropolitan Life Ins., Contract #GAC29114RT                                  | 3.90%            | 5/15/2009              | 4,609,805                       |  | 4,610      | 4,610        
|Monumental Life, Contract #SV04488Q                                           | 4.50%            | 11/15/2009             | 3,628,942                       |  | 3,629      | 3,629        
|Monumental Life, Contract #SV04238Q                                           | 5.90%            | 6/15/2007              | 6,211,055                       |  | 6,211      | 6,211        
|Monumental Life, Contract #SV04566Q                                           | 4.49%            | 8/16/2010              | 5,065,403                       |  | 5,065      | 5,065        
|New York Life, Contract #GA-31404                                             | 5.27%            | 9/14/2007              | 3,054,144                       |  | 3,054      | 3,054        
|Principal Life Insurance, Contract #05924-1                                   | 4.08%            | 9/15/2008              | 5,059,514                       |  | 5,059      | 5,059        
|Principal Life Insurance, Contract #05924-2                                   | 4.42%            | 5/14/2010              | 3,581,391                       |  | 3,581      | 3,581        
|Protective Life, Contract #GA-1893                                            | 5.00%            | 11/15/2010             | 5,011,375                       |  | 5,011      | 5,011        
|Security Life of Denver, Contract #SA-0364                                    | 5.68%            | 6/15/2007              | 4,067,169                       |  | 4,067      | 4,067        
|Security Life of Denver, Contract #SA-0379                                    | 5.46%            | 3/15/2007              | 2,433,157                       |  | 2,433      | 2,433        
|Traveler's Contract #GR-18235                                                 | 5.88%            | 4/9/2007               | 5,751,829                       |  | 5,752      | 5,752        
|Travelers Contract #GR-18251                                                  | 5.46%            | 3/15/2007              | 3,088,674                       |  | 3,089      | 3,089        
|T.Rowe Price, Stable Value Fund--Short-Term
  Investment Fund                 |                  |                        | 18,755,655                      |  | 18,756     | 18,756       
|Collective Short-Term Investment Fund                                         |                  |                        | 823,355                         |  | 823        | 823          
|The Northern Trust Company*, Government Short-Term
  Investment Fund          |                  |                        | 110,839                         |  | 111        | 111          
|                                                                              |                  |                        |                                 |  | 324,883    | 324,883      
|                                                                              |                  |                        |                                 |  |            |              
|Total Participant Directed                                                    |                  |                        |                                 |  | $2,442,541 | $3,159,797   
|                                                                              |                  |                        |                                 |  |            |              
|Loans to Participants  (9,293 loans)                                          | 4.14% to 11.64%  | Jan. 2006 to Dec. 2020 |                                 |  |            | 72,052       
|                                                                              |                  |                        |                                 |  |            |              
|Total                                                                         |                  |                        |                                 |  |            | $4,440,972   

*
Party-in-interest as defined by ERISA

See accompanying report of independent registered
public accounting firm.



SCHEDULE II
PFIZER SAVINGS PLAN
SCHEDULE H, LINE 4j - SCHEDULE OF REPORTABLE TRANSACTIONS
Year Ended December 31, 2005
(thousands of dollars)



(a)
  Identity of
  party involved
  
  (b)
  Description
  of asset
  
  (c)
  Purchase
  price
  
  (d)
  Selling
  price
  
  (g)
  Cost
  of asset
  
  (h)
  Current
  value of
  asset on
  transaction
  date
  
  (i)
  Net gain/
  (loss)Pfizer Inc*
  
  Common stock - 28 purchases
  
  $117,525
  
  $
           --
  
  $117,525
  
  $117,525
  
  $        --Pfizer Inc*
  
  Common stock -134 sales
  
  $          --
  
  $117,878
  
  $47,756
  
  $117,878
  
  $70,122




*
  Party-in-interest
  as defined by ERISA




See accompanying report of independent registered
public accounting firm.





SIGNATURE

The
Plan.Pursuant to the requirements
of the Securities Exchange Act of 1934, the members of the Savings Plan
Committee have duly caused this annual report to be signed on its behalf by the
undersigned thereunto duly authorized.

PFIZER SAVINGS PLANBy:/s/ 
  Richard A. PassovRichard
  A. Passov
  Chair, Savings Plan Committee


Date:  June
29, 2006



EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM



To the Savings Plan Committee
Pfizer Savings Plan:

We
consent to the incorporation by reference in the Registration Statement on Forms S-8
dated October 5, 1994 (File No. 33-55771) and June 19, 2000
(File No. 333-39610) of our report dated June 22, 2006, relating to
the statements of net assets available for plan benefits of the Pfizer Savings
Plan as of December 31, 2005 and 2004, and the related statements of
changes in net assets available for plan benefits for each of the years then
ended, and the related supplemental schedule H, line 4i - schedule of
assets (held at end of year) as of December 31, 2005 and schedule H, line 4j
- schedule of reportable transactions for the year ended December 31,
2005, which report appears in the December 31, 2005 annual report on
Form 11-K of the Pfizer Savings Plan.

/s/ KPMG LLP

Memphis, Tennessee

June 22, 2006